Speaker illustration

Doctor David Garcia Vega

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

Combined therapy with SGLT2i and GLP-1ra improves cardiovascular prognosis in a population with diabetes and overweigh or obesity. A real-world clinical practice study

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Diabetes and the heart (2)

Thumbnail

A universal electronic consultation programme at the cardiology department after general practitioner referrals improves healthcare outcomes in patients with health failure

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Epidemiology, prognosis, and outcomes in acute heart failure

Thumbnail

An electronic consultation programme impacts on heart failure patients prognosis: implications for heart failure care

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Epidemiology, prognosis, and outcomes in acute heart failure

Thumbnail

A universal electronic consultation programme at the cardiology department after general practitioner referrals to improve healthcare accessibility and outcomes in elderly patients

Event: ESC Congress 2022

Topic: Cardiovascular Disease in the Elderly

Session: Cardiovascular disease in the elderly 2

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb